Anesthetic induction using remimazolam in patients undergoing cardiac surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0006931

Enrollment

Registered

2022-01-17

Start date

2022-04-08

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Randomly assigned the subjects into three group, remimazolam was infused as followed 1) Continuous infusion (6mg/kg/hr) group 2) Rapid infusion group A (0.1mg/kg) 3) Rapid infusion group B (0.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients undergoing elective cardiac surgery Adults (20~80 years) with Written informed consent

Exclusion criteria

Exclusion criteria: Rrefusal of informed consent The history of hyper-reaction or allergic reaction to benzodiazepine or flumazenil Urgent surgery More than 2 times elevation of normal limit in aspartate aminotransferase/ alanine aminotransferase within a week More than 3.0 mg/dL of total bilirubin within a week Alcohol or drug abuser

Design outcomes

Primary

Measure	Time frame
Measure the time until the subjects lost consciousness	—

Secondary

Measure	Time frame
observed the changes of hemodynamics until 5 minutes.	—

Countries

Korea, Republic of

Contacts

Public ContactKyungmi Kim

Asan Medical Center

liebenadia@nate.com+82-2-3010-3868

Outcome results